Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Get this document free

Rentokil Initial plc: Business and Consumer Services Company Profile, SWOT & Financial Report

VIEWS: 14 PAGES: 38

ICD Research's "Rentokil Initial plc: Business and Consumer Services Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.

More Info
									Rentokil Initial plc

_________________________________________________________________________________



Rentokil Initial plc                                                     Financial Snapshot

                                                                         Operating Performance
Fast Facts
                                      Belgrave House, London, SW1W       The company reported revenue of US$3,840.77
Headquarters Address
                                      9RF,United Kingdom                 million during the fiscal year 2010 (2010). The
                                                                         company's revenue grew at a CAGR of 2.99% during
Telephone                             + 44 207 8663000
                                                                         2006–2010, with an annual decline of 2.87% over
                                                                         2009. In 2010, the company recorded an operating
Fax                                   + 44 207 8663800                   margin of 2.46%, as against 4.71% in 2009.

Website                               www.rentokil-initial.com
                                                                         Revenue and Margins
Ticker Symbol, Stock Exchange         RTO, London Stock Exchange (LON)

Number of Employees                   66,364

Fiscal Year End                       December

Revenue (in US$ million)              3,840.77

Revenue (in GBP million)              2,496.50




SWOT Analysis                                                            Return on Equity

Strengths                             Weaknesses                         The company recorded a return on equity (ROE) of
                                                                         0.00% for 2010, as compared to its peers, Rollins,
Diversified business operations       Weak financial performance         Inc. (Ticker: ROL), Healthcare Services Group, Inc.
                                                                         (Ticker: HCSG) and ABM Industries Incorporated
                                                                         (Ticker: ABM), which recorded ROEs of 30.21%,
Strong inorganic growth               Weak liquidity position            16.16% and 8.68% respectively. The company
                                                                         reported an operating margin of 2.46% in 2010.
Wide geographical presence
                                                                         Return on Equity
Opportunities                         Threats

Acquisition of Services Division      Changing labor conditions

Emerging markets                      Environmental regulations

Improved processing structure         Foreign exchange risks




                                                                         Liquidity Position

                                                                         The company reported a current ratio of 0.77 in 2010,
                                                                         as compared to its peers, Rollins, Inc., Healthcare
                                                                         Services Group, Inc. and ABM Industries
                                                                         Incorporated, which recorded current ratios of 0.61,
                                                                         5.47 and 1.82 respectively. As of December 2010, the
                                                                         company recorded cash and short-term investments
                                                                         of worth US$125.23 million, against US$60.46 million
                                                                         current debt. The company reported a debt to equity
                                                                         ratio of -7.71 in 2010 as compared to its peers,
                                                                         Rollins, Inc., Healthcare Services Group, Inc. and
                                                                         ABM Industries Incorporated, which recorded debt to
                                                                         equity ratios of 0.09, 0.00 and 0.19 respectively.




___________________________________________________________________________________________

Rentokil Initial plc - SWOT Profile                                                                             Page 1
Rentokil Initial plc

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Business Description ..............................................................................................................................................5
    1.3       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 7
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
    2.2       Key Financial Performance Indicators .................................................................................................................10
      2.2.1       Revenue and Operating Profit .........................................................................................................................10
      2.2.2       Asset, Liabilities and Capex .............................................................................................................................11
      2.2.3       Net Debt vs. Gearing Ratio ..............................................................................................................................12
      2.2.4       Solvency ..........................................................................................................................................................13
      2.2.5       Valuation ..........................................................................................................................................................14
    2.3       Competitive Benchmarking ..................................................................................................................................15
      2.3.1       Market Capitalization .......................................................................................................................................16
      2.3.2       Efficiency ..........................................................................................................................................................17
      2.3.3       Capital Expenditure ..........................................................................................................................................18
      2.3.4       Turnover – Inventory and Asset .......................................................................................................................19
3     Mergers & Acquisitions and Partnerships ........................................................................................... 20
    3.1       M&A and Partnerships Strategy ...........................................................................................................................20
4     Recent Developments ........................................................................................................................... 21
5     SWOT Analysis ...................................................................................................................................... 22
    5.1       SWOT Analysis - Overview ..................................................................................................................................22
    5.2       Strengths ..............................................................................................................................................................22
    5.3       Weaknesses .........................................................................................................................................................22
    5.4       Opportunities ........................................................................................................................................................23
    5.5       Threats .................................................................................................................................................................23
6     Company Statement ..........
								
To top